Skip to main content

Table 5 Suspected drug, ADR, outcome and causality

From: Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Suspected drugs Patient on treatment ADR Outcome Causalitya
Recovered Recovering Probable Possible
Atazanavir 167 88 (52.7%) 57 29 57 29
Chloroquine 19 7 (36.8%) 7 0 0 7
Lopinavir/ritonavir 214 78 (36.4%) 75 3 18 60
Ribavirin 7 1 (14.3%) 1 0 1 0
Hydroxychloroquine 1035 118 (11.4%) 107 11 22 96
Interferon beta-1b 91 3 (4.4%) 3 0 0 3
Tocilizumab 8 0 0 0 0 0
Favipiravir 6 0 0 0 0 0
  1. ADR is reported as n (%), where % is calculated by taking ADR/patient on treatment
  2. aNo ADR cases were classified as certain